Clinical trials
Phase 1 Uterine Cervical Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 8 |
| Active, not recruiting | 5 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| MacroGenics | 2 |
| AbbVie | 1 |
| Actym Therapeutics, Inc. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Antiva Biosciences | 1 |
| Arcus Biosciences, Inc. | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Exelixis | 1 |
| Fusion Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 24 |
| Ovarian Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Triple Negative Breast Neoplasms | 14 |
| Squamous Cell Carcinoma of Head and Neck | 12 |
| Breast Neoplasms | 11 |
| Colorectal Neoplasms | 11 |
| Endometrial Neoplasms | 11 |
| Pancreatic Neoplasms | 10 |
| Urinary Bladder Neoplasms | 10 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.